1
|
Miron RJ, Fujioka-Kobayashi M, Pikos MA, Nakamura T, Imafuji T, Zhang Y, Shinohara Y, Sculean A, Shirakata Y. The development of non-resorbable bone allografts: Biological background and clinical perspectives. Periodontol 2000 2024; 94:161-179. [PMID: 38323368 DOI: 10.1111/prd.12551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2023] [Revised: 01/04/2024] [Accepted: 01/08/2024] [Indexed: 02/08/2024]
Abstract
Bone grafts are typically categorized into four categories: autografts, allografts, xenografts, and synthetic alloplasts. While it was originally thought that all bone grafts should be slowly resorbed and replaced with native bone over time, accumulating evidence has in fact suggested that the use of nonresorbable xenografts is favored for certain clinical indications. Thus, many clinicians take advantage of the nonresorbable properties/features of xenografts for various clinical indications, such as contour augmentation, sinus grafting, and guided bone regeneration, which are often combined with allografts (e.g., human freeze-dried bone allografts [FDBAs] and human demineralized freeze-dried bone allografts [DFDBAs]). Thus, many clinicians have advocated different 50/50 or 70/30 ratios of allograft/xenograft combination approaches for various grafting procedures. Interestingly, many clinicians believe that one of the main reasons for the nonresorbability or low substitution rates of xenografts has to do with their foreign animal origin. Recent research has indicated that the sintering technique and heating conducted during their processing changes the dissolution rate of hydroxyapatite, leading to a state in which osteoclasts are no longer able to resorb (dissolve) the sintered bone. While many clinicians often combine nonresorbable xenografts with the bone-inducing properties of allografts for a variety of bone augmentation procedures, clinicians are forced to use two separate products owing to their origins (the FDA/CE does not allow the mixture of allografts with xenografts within the same dish/bottle). This has led to significant progress in understanding the dissolution rates of xenografts at various sintering temperature changes, which has since led to the breakthrough development of nonresorbable bone allografts sintered at similar temperatures to nonresorbable xenografts. The advantage of the nonresorbable bone allograft is that they can now be combined with standard allografts to create a single mixture combining the advantages of both allografts and xenografts while allowing the purchase and use of a single product. This review article presents the concept with evidence derived from a 52-week monkey study that demonstrated little to no resorption along with in vitro data supporting this novel technology as a "next-generation" biomaterial with optimized bone grafting material properties.
Collapse
Affiliation(s)
- Richard J Miron
- Department of Periodontology, University of Bern, Bern, Switzerland
| | - Masako Fujioka-Kobayashi
- Department of Oral and Maxillofacial Surgery, School of Life Dentistry at Tokyo, The Nippon Dental University, Tokyo, Japan
| | | | - Toshiaki Nakamura
- Department of Periodontology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
| | - Takatomo Imafuji
- Department of Periodontology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
| | - Yufeng Zhang
- Department of Oral Implantology, University of Wuhan, Wuhan, China
| | - Yukiya Shinohara
- Department of Periodontology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
| | - Anton Sculean
- Department of Periodontology, University of Bern, Bern, Switzerland
| | - Yoshinori Shirakata
- Department of Periodontology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
| |
Collapse
|
2
|
Söhling N, Heilani M, Fremdling C, Schaible A, Schröder K, Brune JC, Eras V, Nau C, Marzi I, Henrich D, Verboket RD. One Stage Masquelets Technique: Evaluation of Different Forms of Membrane Filling with and without Bone Marrow Mononuclear Cells (BMC) in Large Femoral Bone Defects in Rats. Cells 2023; 12:cells12091289. [PMID: 37174689 PMCID: PMC10177115 DOI: 10.3390/cells12091289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2023] [Revised: 04/23/2023] [Accepted: 04/28/2023] [Indexed: 05/15/2023] Open
Abstract
The classic two-stage masquelet technique is an effective procedure for the treatment of large bone defects. Our group recently showed that one surgery could be saved by using a decellularized dermis membrane (DCD, Epiflex, DIZG). In addition, studies with bone substitute materials for defect filling show that it also appears possible to dispense with the removal of syngeneic cancellous bone (SCB), which is fraught with complications. The focus of this work was to clarify whether the SCB can be replaced by the granular demineralized bone matrix (g-DBM) or fibrous demineralized bone matrix (f-DBM) demineralized bone matrix and whether the colonization of the DCD and/or the DBM defect filling with bone marrow mononuclear cells (BMC) can lead to improved bone healing. In 100 Sprague Dawley rats, a critical femoral bone defect 5 mm in length was stabilized with a plate and then encased in DCD. Subsequently, the defect was filled with SCB (control), g-DBM, or f-DBM, with or without BMC. After 8 weeks, the femurs were harvested and subjected to histological, radiological, and biomechanical analysis. The analyses showed the incipient bony bridging of the defect zone in both groups for g-DBM and f-DBM. Stability and bone formation were not affected compared to the control group. The addition of BMCs showed no further improvement in bone healing. In conclusion, DBM offers a new perspective on defect filling; however, the addition of BMC did not lead to better results.
Collapse
Affiliation(s)
- Nicolas Söhling
- Department of Trauma, Hand and Reconstructive Surgery, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany
| | - Myriam Heilani
- Department of Trauma, Hand and Reconstructive Surgery, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany
| | - Charlotte Fremdling
- Department of Trauma, Hand and Reconstructive Surgery, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany
| | - Alexander Schaible
- Department of Trauma, Hand and Reconstructive Surgery, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany
| | - Katrin Schröder
- Center of Physiology, Cardiovascular Physiology, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany
| | - Jan C Brune
- German Institute for Cell and Tissue Replacement (DIZG, gemeinnützige GmbH), 12555 Berlin, Germany
| | - Volker Eras
- German Institute for Cell and Tissue Replacement (DIZG, gemeinnützige GmbH), 12555 Berlin, Germany
| | - Christoph Nau
- Department of Trauma, Hand and Reconstructive Surgery, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany
| | - Ingo Marzi
- Department of Trauma, Hand and Reconstructive Surgery, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany
| | - Dirk Henrich
- Department of Trauma, Hand and Reconstructive Surgery, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany
| | - René D Verboket
- Department of Trauma, Hand and Reconstructive Surgery, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany
| |
Collapse
|
3
|
Verboket RD, Söhling N, Heilani M, Fremdling C, Schaible A, Schröder K, Brune JC, Marzi I, Henrich D. The Induced Membrane Technique—The Filling Matters: Evaluation of Different Forms of Membrane Filling with and without Bone Marrow Mononuclear Cells (BMC) in Large Femoral Bone Defects in Rats. Biomedicines 2022; 10:biomedicines10030642. [PMID: 35327444 PMCID: PMC8945121 DOI: 10.3390/biomedicines10030642] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2022] [Revised: 03/07/2022] [Accepted: 03/08/2022] [Indexed: 12/04/2022] Open
Abstract
The Masquelet technique is used to treat large bone defects; it is a two-stage procedure based on an induced membrane. To improve the induced membrane process, demineralized bone matrix in granular (GDBM) and fibrous form (f-DBM) was tested with and without bone marrow mononuclear cells (BMC) as filling of the membrane against the gold standard filling with syngeneic cancellous bone (SCB). A total of 65 male Sprague–Dawley rats obtained a 5 mm femoral defect. These defects were treated with the induced membrane technique and filled with SCB, GDBM, or f-DBM, with or without BMC. After a healing period of eight weeks, the femurs were harvested and submitted for histological, radiological, and biomechanical analyses. The fracture load in the defect zone was lower compared to SCB in all groups. However, histological analysis showed comparable new bone formation, bone mineral density, and cartilage proportions and vascularization. The results suggest that f-DBM in combination with BMC and the induced membrane technique cannot reproduce the very good results of this material in large, non-membrane coated bone defects, nevertheless it supports the maturation of new bone tissue locally. It can be concluded that BMC should be applied in lower doses and inflammatory cells should be removed from the cell preparation before implantation.
Collapse
Affiliation(s)
- René D. Verboket
- Department of Trauma, Hand and Reconstructive Surgery, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany; (N.S.); (M.H.); (C.F.); (A.S.); (I.M.); (D.H.)
- Correspondence: ; Tel.: +49-69-6301-7110
| | - Nicolas Söhling
- Department of Trauma, Hand and Reconstructive Surgery, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany; (N.S.); (M.H.); (C.F.); (A.S.); (I.M.); (D.H.)
| | - Myriam Heilani
- Department of Trauma, Hand and Reconstructive Surgery, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany; (N.S.); (M.H.); (C.F.); (A.S.); (I.M.); (D.H.)
| | - Charlotte Fremdling
- Department of Trauma, Hand and Reconstructive Surgery, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany; (N.S.); (M.H.); (C.F.); (A.S.); (I.M.); (D.H.)
| | - Alexander Schaible
- Department of Trauma, Hand and Reconstructive Surgery, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany; (N.S.); (M.H.); (C.F.); (A.S.); (I.M.); (D.H.)
| | - Katrin Schröder
- Center of Physiology, Cardiovascular Physiology, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany;
| | - Jan C. Brune
- German Institute for Cell and Tissue Replacement (DIZG, gemeinnützige GmbH), 12555 Berlin, Germany;
| | - Ingo Marzi
- Department of Trauma, Hand and Reconstructive Surgery, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany; (N.S.); (M.H.); (C.F.); (A.S.); (I.M.); (D.H.)
| | - Dirk Henrich
- Department of Trauma, Hand and Reconstructive Surgery, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany; (N.S.); (M.H.); (C.F.); (A.S.); (I.M.); (D.H.)
| |
Collapse
|
4
|
Silva DF, Friis TE, Camargo NHA, Xiao Y. Characterization of mesoporous calcium phosphates from calcareous marine sediments containing Si, Sr and Zn for bone tissue engineering. J Mater Chem B 2016; 4:6842-6855. [PMID: 32263578 DOI: 10.1039/c6tb02255c] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Calcium phosphates (CAPs) can be produced from either biologically sourced materials or mineral deposits. The raw materials impart unique properties to the CAPs due to innate trace amounts of elements that affect the crystal structure, morphology and stoichiometry. Using calcium carbonate (CaCO3) precursors derived from fossilized calcareous marine sediments (FCMSs), we have synthesized a novel class of CAP biomaterials, termed fm-CaPs, with defined Ca/P molar ratios of 1.4 and 1.7 using a wet synthesis method. Compared with commercially available CAP biomaterials, such as hydroxyapatite (HA) and beta-tricalcium phosphate (β-TCP), fm-CaP1.7 had a biphasic composition consisting of an HA phase (in a hexagonal system) and a β-TCP phase (in a rhombohedral crystalline system), which is desirable for the current design of bone substitutes, whereas fm-CaP1.4 consisted of an HA phase and a beta-dicalcium pyrophosphate phase (in a tetragonal system). These bioceramics exhibited a fringe structure of regular crystallographic orientation with well-ordered mesoporous channels. The FCMS raw material imparted trace amounts of silicon (Si), strontium (Sr) and zinc (Zn) to fm-CaPs; these are elements that are important for bone formation. The cyto-compatibility of these biomaterials and their effects on cellular activity were evaluated using osteoblast cells. Cell proliferation assays revealed no signs of cytotoxicity, whereas cells growth was equal to or better than HA and β-TCP controls. The SEM analysis of the cell and material interactions showed good cell spreading on the fm-CaP materials that was comparable to β-TCP and in vitro assays suggested robust osteogenic differentiation, as seen by increased mineralization (alizarin red) and upregulation of osteogenic gene expression. Our results indicate that fm-CaP1.7, in particular, has chemical, physical and morphological properties that make this material suitable for applications that promote bone tissue regeneration.
Collapse
Affiliation(s)
- D F Silva
- Programa de Pós Graduação em Ciência e Engenharia de Materiais, Universidade do Estado de Santa Catarina, 89.223-100, Joinville, SC, Brazil.
| | | | | | | |
Collapse
|
5
|
Kuo YJ, Sun JS, Rau G, Chen CH, Tsai TH, Tsuang YH. Better Osteoporotic Fracture Healing with Sintered Dicalcium Pyrophosphate (SDCP) Treatment: A Rat Femoral Fracture Model. J Histochem Cytochem 2014; 62:565-76. [PMID: 24828625 DOI: 10.1369/0022155414538264] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2013] [Accepted: 04/24/2014] [Indexed: 01/08/2023] Open
Abstract
The aim of this study was to evaluate the effect of sintered dicalcium pyrophosphate (SDCP) on fracture healing in an osteoporotic rat model. Female Sprague-Dawley rats (8 weeks old) were randomly allocated into five groups: sham-operated group, and bilateral ovariectomized group treated with SDCP, alendronate, calcitonin, or no treatment. Rats were sacrificed at 6 or 16 weeks after fracture. Fracture sites were examined by microcomputed tomography (microCT), histology, and mechanical testing. The results showed that SDCP mildly suppressed callus remodeling at 6 weeks, but not at 16 weeks. The lamellar bone in the callus area and new cortical shell formation in SDCP-treated group were similar to that of the sham group at 16 weeks after fracture, indicating there was no delayed callus remodeling into lamellar bone. At both 6 and 16 weeks after fracture, ultimate stress and elastic modulus were similar between the SDCP and sham groups, and the mechanical strength in these groups was better than that in other groups. Finally, analysis of the serum bone markers CTX-1 and P1NP suggested that SDCP decreased the bone turnover rate and promoted proper fracture healing. The effect of SDCP is superior to that of alendronate and calcitonin in the healing of osteoporotic fractures.
Collapse
Affiliation(s)
- Yi-Jie Kuo
- Institute of Clinical Medicine (YJK, JSS) National Yang Ming University, Taipei, TaiwanInstitute of Microbiology and Immunology (CHC) National Yang Ming University, Taipei, TaiwanInstitute of Traditional Medicine (THT, YHT) National Yang Ming University, Taipei, TaiwanDepartment of Orthopaedics (YJK), School of Medicine, College of MedicineGraduate Institute of Clinical Medicine (JSS, GR), School of Medicine, College of MedicineDepartment of Orthopaedics, Shang-Ho Hospital (GR, CHC, YHT) Taipei Medical University, Taipei, TaiwanDepartment of Orthopaedic Surgery, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)Department of Orthopaedics, Shang-Ho Hospital (CHC, GR, YHT)Department of Orthopaedics, School of Medicine, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)
| | - Jui-Sheng Sun
- Institute of Clinical Medicine (YJK, JSS) National Yang Ming University, Taipei, TaiwanInstitute of Microbiology and Immunology (CHC) National Yang Ming University, Taipei, TaiwanInstitute of Traditional Medicine (THT, YHT) National Yang Ming University, Taipei, TaiwanDepartment of Orthopaedics (YJK), School of Medicine, College of MedicineGraduate Institute of Clinical Medicine (JSS, GR), School of Medicine, College of MedicineDepartment of Orthopaedics, Shang-Ho Hospital (GR, CHC, YHT) Taipei Medical University, Taipei, TaiwanDepartment of Orthopaedic Surgery, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)Department of Orthopaedics, Shang-Ho Hospital (CHC, GR, YHT)Department of Orthopaedics, School of Medicine, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)
| | - Gary Rau
- Institute of Clinical Medicine (YJK, JSS) National Yang Ming University, Taipei, TaiwanInstitute of Microbiology and Immunology (CHC) National Yang Ming University, Taipei, TaiwanInstitute of Traditional Medicine (THT, YHT) National Yang Ming University, Taipei, TaiwanDepartment of Orthopaedics (YJK), School of Medicine, College of MedicineGraduate Institute of Clinical Medicine (JSS, GR), School of Medicine, College of MedicineDepartment of Orthopaedics, Shang-Ho Hospital (GR, CHC, YHT) Taipei Medical University, Taipei, TaiwanDepartment of Orthopaedic Surgery, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)Department of Orthopaedics, Shang-Ho Hospital (CHC, GR, YHT)Department of Orthopaedics, School of Medicine, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)
| | - Chia-Hsien Chen
- Institute of Clinical Medicine (YJK, JSS) National Yang Ming University, Taipei, TaiwanInstitute of Microbiology and Immunology (CHC) National Yang Ming University, Taipei, TaiwanInstitute of Traditional Medicine (THT, YHT) National Yang Ming University, Taipei, TaiwanDepartment of Orthopaedics (YJK), School of Medicine, College of MedicineGraduate Institute of Clinical Medicine (JSS, GR), School of Medicine, College of MedicineDepartment of Orthopaedics, Shang-Ho Hospital (GR, CHC, YHT) Taipei Medical University, Taipei, TaiwanDepartment of Orthopaedic Surgery, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)Department of Orthopaedics, Shang-Ho Hospital (CHC, GR, YHT)Department of Orthopaedics, School of Medicine, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)
| | - Tung-Hu Tsai
- Institute of Clinical Medicine (YJK, JSS) National Yang Ming University, Taipei, TaiwanInstitute of Microbiology and Immunology (CHC) National Yang Ming University, Taipei, TaiwanInstitute of Traditional Medicine (THT, YHT) National Yang Ming University, Taipei, TaiwanDepartment of Orthopaedics (YJK), School of Medicine, College of MedicineGraduate Institute of Clinical Medicine (JSS, GR), School of Medicine, College of MedicineDepartment of Orthopaedics, Shang-Ho Hospital (GR, CHC, YHT) Taipei Medical University, Taipei, TaiwanDepartment of Orthopaedic Surgery, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)Department of Orthopaedics, Shang-Ho Hospital (CHC, GR, YHT)Department of Orthopaedics, School of Medicine, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)
| | - Yang-Hwei Tsuang
- Institute of Clinical Medicine (YJK, JSS) National Yang Ming University, Taipei, TaiwanInstitute of Microbiology and Immunology (CHC) National Yang Ming University, Taipei, TaiwanInstitute of Traditional Medicine (THT, YHT) National Yang Ming University, Taipei, TaiwanDepartment of Orthopaedics (YJK), School of Medicine, College of MedicineGraduate Institute of Clinical Medicine (JSS, GR), School of Medicine, College of MedicineDepartment of Orthopaedics, Shang-Ho Hospital (GR, CHC, YHT) Taipei Medical University, Taipei, TaiwanDepartment of Orthopaedic Surgery, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)Department of Orthopaedics, Shang-Ho Hospital (CHC, GR, YHT)Department of Orthopaedics, School of Medicine, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)
| |
Collapse
|
6
|
Kuo YJ, Tsuang FY, Sun JS, Lin CH, Chen CH, Li JY, Huang YC, Chen WY, Yeh CB, Shyu JF. Calcitonin inhibits SDCP-induced osteoclast apoptosis and increases its efficacy in a rat model of osteoporosis. PLoS One 2012; 7:e40272. [PMID: 22792258 PMCID: PMC3391248 DOI: 10.1371/journal.pone.0040272] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2012] [Accepted: 06/04/2012] [Indexed: 12/13/2022] Open
Abstract
Introduction Treatment for osteoporosis commonly includes the use of bisphosphonates. Serious side effects of these drugs are caused by the inhibition of bone resorption as a result of osteoclast apoptosis. Treatment using calcitonin along with bisphosphonates overcomes these side-effects in some patients. Calcitonin is known to inhibit bone resorption without reducing the number of osteoclasts and is thought to prolong osteoclast survival through the inhibition of apoptosis. Further understanding of how calcitonin inhibits apoptosis could prove useful to the development of alternative treatment regimens for osteoporosis. This study aimed to analyze the mechanism by which calcitonin influences osteoclast apoptosis induced by a bisphosphate analog, sintered dicalcium pyrophosphate (SDCP), and to determine the effects of co-treatment with calcitonin and SDCP on apoptotic signaling in osteoclasts. Methods Isolated osteoclasts were treated with CT, SDCP or both for 48 h. Osteoclast apoptosis assays, pit formation assays, and tartrate-resistant acid phosphatase (TRAP) staining were performed. Using an osteoporosis rat model, ovariectomized (OVX) rats received calcitonin, SDCP, or calcitonin + SDCP. The microarchitecture of the fifth lumbar trabecular bone was investigated, and histomorphometric and biochemical analyses were performed. Results Calcitonin inhibited SDCP-induced apoptosis in primary osteoclast cultures, increased Bcl-2 and Erk activity, and decreased Mcl-1 activity. Calcitonin prevented decreased osteoclast survival but not resorption induced by SDCP. Histomorphometric analysis of the tibia revealed increased bone formation, and microcomputed tomography of the fifth lumbar vertebrate showed an additive effect of calcitonin and SDCP on bone volume. Finally, analysis of the serum bone markers CTX-I and P1NP suggests that the increased bone volume induced by co-treatment with calcitonin and SDCP may be due to decreased bone resorption and increased bone formation. Conclusions Calcitonin reduces SDCP-induced osteoclast apoptosis and increases its efficacy in an in vivo model of osteoporosis.
Collapse
Affiliation(s)
- Yi-Jie Kuo
- Department of Orthopaedic, Taipei Medical University Hospital, Taipei, Taiwan, Republic of China
- Institute of Clinical Medicine, National Yang Ming University, Taipei, Taiwan, Republic of China
| | - Fon-Yih Tsuang
- Division of Neurosurgery, Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan, Republic of China
| | - Jui-Sheng Sun
- Department of Orthopaedic Surgery, National Taiwan University Hospital-Hsin Chu, Hsin-Chu, Taiwan, Republic of China
- Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, Republic of China
| | - Chi-Hung Lin
- Institute of Microbiology and Immunology, National Yang Ming University, Taipei, Taiwan, Republic of China
| | - Chia-Hsien Chen
- Institute of Microbiology and Immunology, National Yang Ming University, Taipei, Taiwan, Republic of China
| | - Jia-Ying Li
- Department of Biology and Anatomy, National Defense Medical Center, Taipei, Taiwan, Republic of China
| | - Yi-Chian Huang
- Institute of Anatomy and Cell Biology National Yang Ming University, Taipei, Taiwan, Republic of China
| | - Wei-Yu Chen
- Department of Biology and Anatomy, National Defense Medical Center, Taipei, Taiwan, Republic of China
| | - Chin-Bin Yeh
- Department of Psychiatry, Tri-Service General Hospital, Taipei, Taiwan, Republic of China
| | - Jia-Fwu Shyu
- Department of Biology and Anatomy, National Defense Medical Center, Taipei, Taiwan, Republic of China
- Department of Psychiatry, Tri-Service General Hospital, Taipei, Taiwan, Republic of China
- * E-mail:
| |
Collapse
|
7
|
Ince A, Schütze N, Hendrich C, Thull R, Eulert J, Löhr JF. In vitro investigation of orthopedic titanium-coated and brushite-coated surfaces using human osteoblasts in the presence of gentamycin. J Arthroplasty 2008; 23:762-71. [PMID: 18534525 DOI: 10.1016/j.arth.2007.06.018] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/29/2006] [Revised: 02/05/2007] [Accepted: 06/15/2007] [Indexed: 02/01/2023] Open
Abstract
Anti-infective coatings have been developed to protect the surfaces of cementless implants from bacterial colonization that is known to be a prerequisite for device-related infection. The aim of this study is to investigate the effect of brushite-coated arthroplasty surfaces on human osteoblasts and to evaluate the impact of concomitant exposure to gentamycin. We cultured human osteoblasts (hFOB 1.19) on brushite-coated and uncoated titanium alloy in the presence of gentamycin and analyzed cell function and vitality. Our results show that brushite-coated titanium alloy surfaces supported the function of osteoblasts and the expression of extracellular matrix even in the presence of highly dosed gentamycin. Brushite-coated titanium alloy surfaces supported osteogenic function, indicating that this coating could enhance implant osteointegration in vivo. Concomitant exposure to gentamycin slightly decreased osteoblastic activity in vitro, suggesting that there might also be negative effects in vivo. However, in vivo studies are necessary to validate these in vitro findings.
Collapse
Affiliation(s)
- Akif Ince
- Department of Orthopaedic Surgery, University Hospital Würzburg, Würzburg, Germany
| | | | | | | | | | | |
Collapse
|
8
|
Bruinink A, Schroeder A, Francz G, Hauert R. In vitro studies on the effect of delaminated a-C:H film fragments on bone marrow cell cultures. Biomaterials 2005; 26:3487-94. [PMID: 15621238 DOI: 10.1016/j.biomaterials.2004.09.030] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2004] [Accepted: 09/20/2004] [Indexed: 01/22/2023]
Abstract
Amorphous hydrogenated carbon (a-C:H) films have many outstanding properties required for a protective coating material on load bearing medical implants. Recently, titanium doped a-C:H films have been evaluated regarding their effects on bone marrow cell cultures. But many materials that are well-tolerated in bulk form are able to induce toxic reaction if present particulate form. In order to further assess biocompatibility aspects of these two coatings, film delamination has been mimicked in exposure to fluids. In the present study, particles from a-C:H, a-C:H/Ti and a-C:H-a-C:H/Ti bilayer films were added to bone marrow cell cultures in vitro. The results showed that plain a-C:H and to a certain extent a-CH/Ti particles were inert. Both kinds of particles did not significantly stimulate the osteoclast-related enzyme tartrate resistant acid phosphatase (TRAP). A slight increase in cell proliferation and total culture TRAP was found in cultures treated by a-C:H-a-C:H/Ti bilayer films. Latter effect can probably be traced back by the relative high percentage of small particles of a size of around 2 microm. However, if corrected by the cell number also no differences between particle-treated and untreated control cultures could be found, indicating the absence of a toxic effect from delaminated a-C:H coatings.
Collapse
Affiliation(s)
- Arie Bruinink
- EMPA Swiss Federal Laboratories for Materials Testing and Research, St. Gallen, Switzerland.
| | | | | | | |
Collapse
|
9
|
Park EK, Lee YE, Choi JY, Oh SH, Shin HI, Kim KH, Kim SY, Kim S. Cellular biocompatibility and stimulatory effects of calcium metaphosphate on osteoblastic differentiation of human bone marrow-derived stromal cells. Biomaterials 2004; 25:3403-11. [PMID: 15020113 DOI: 10.1016/j.biomaterials.2003.10.031] [Citation(s) in RCA: 53] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2003] [Accepted: 10/08/2003] [Indexed: 11/29/2022]
Abstract
In the present study, the in vitro biocompatibility of calcium metaphosphate (CMP) with human bone marrow stromal cells (HBMSCs) and its effect on osteoblastic differentiation have been investigated. Powder and disk forms of CMP do not exert a cytotoxic effect on the HBMSCs undergoing osteoblastic differentiation. In addition, the HBMSCs adhere to the surface of the CMP disk as successfully as to the culture plate or hydroxyapatite (HA) disk. The HBMSCs adhered to either the HA or CMP disk display an undistinguishable actin arrangement and cellular phenotypes, indicating that the CMP does not disrupt normal cellular responses. An analysis of the differentiation of the HBMSCs cultured on culture plate, the HA and the CMP disk shows that three matrices are capable of supporting osteoblastic differentiation of the HBMSCs as accessed by alkaline phosphatase (ALP) staining. Further molecular analysis of osteoblastic differentiation of HBMSCs reveals that the CMP disk has a better ability than the HA disk to induce an expression of osteoblast-related genes, including ALP, osteoprotegerin (OPG), a decoy receptor for RANK ligand, and osteopontin (OPN), a non-collagenous bone matrix protein. The results demonstrate that, in addition to favorable biocompatibility, the CMP can stimulate osteoblastic differentiation of the HBMSCs in vitro.
Collapse
Affiliation(s)
- Eui Kyun Park
- Skeletal Diseases Research Center, Kyungpook National University Hospital, Daegu 700-412, South Korea
| | | | | | | | | | | | | | | |
Collapse
|
10
|
Xu H, Shimizu Y, Asai S, Ooya K. Experimental sinus grafting with the use of deproteinized bone particles of different sizes. Clin Oral Implants Res 2003; 14:548-55. [PMID: 12969358 DOI: 10.1034/j.1600-0501.2003.00933.x] [Citation(s) in RCA: 53] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
This study compared the osteoconductive capability of deproteinized bone particles of two different sizes (300-500 and 850-1000 microm) in rabbits undergoing maxillary sinus lift. Histologically, deproteinized bone particles of both sizes induced osteoconduction 1 week after implantation. Bone initially formed at the sinus wall and proliferated into the center of the augmented sinus cavity. In the small-particle group, newly formed bone showed many interconnections and appeared in most areas of the cavity 8 weeks after implantation. In the large-particle group, newly formed bone showed limited intercommunications, and the center of the sinus cavity contained fibrous connective tissue with no evidence of ossification 8 weeks after implantation. Histomorphometric analysis revealed a significantly higher density of newly formed bone in the small-particle group than in the large-particle group both 4 and 8 weeks after implantation. The total newly formed bone-particle contact length was also significantly higher in the small-particle group. The total surface length of the small particles was larger than that of the large particles, but the ratio of the newly formed bone-particle contact length to the total particle surface length did not differ significantly between the groups at any time. The interparticular spaces of the small particles were larger than those of the large particles. The bone area ratio in the interparticular spaces of the small particles was significantly higher than that of the large particles both 4 and 8 weeks after implantation. We conclude that graft bone particle size and interparticular space are important determinants of osteoconduction.
Collapse
Affiliation(s)
- Hui Xu
- Division of Oral Pathology, Tohoku University Graduate School of Dentistry, Sendai, Japan.
| | | | | | | |
Collapse
|
11
|
Sun JS, Tsuang YH, Lin FH, Chen LT, Hang YS, Liu HC. The application potential of sintered beta-dicalcium pyrophosphate in total joint arthroplasty. J Arthroplasty 2003; 18:352-60. [PMID: 12728430 DOI: 10.1054/arth.2003.50054] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
An in vitro bone cell culture model was used to evaluate the potential application of sintered beta-dicalcium pyrophosphate (SDCP) in arthroplasty surgery. Primary osteoclasts and osteoblasts were cocultured with different sizes of SDCP particles. The changes in cell counts and the synthesis and secretion of alkaline phosphatase, acid phosphatase, and prostaglandin E(2) in response to the SDCP particles were monitored. When bone cells were cultured with SDCP particles smaller than 53 microm, both the osteoblast and osteoclast cell counts decreased significantly. When the SDCP particles were larger than 177 microm, although the osteoblast population increased significantly, the osteoclast population decreased significantly. Simultaneously, the titer of prostaglandin E(2) in the medium and the cytoplasmic prostaglandin E(2) increased significantly. We concluded that SDCP is a potentially useful bioceramic for the prevention of osteoclast-mediated periprosthetic osteolysis.
Collapse
Affiliation(s)
- Jui-Sheng Sun
- Department of Biomedical Engineering, National Taiwan University Hospital, No. 1 Jen-Ai Road, Taipei, Taiwan, ROC
| | | | | | | | | | | |
Collapse
|